Phase III trial of Alzheimer’s drug offers hope to patients
Scientists have completed the first phase III clinical trial of a drug that targets a tau, the hallmark protein of Alzheimer’s the forms twisted fibers and neuron death.
http://www.medicalnewstoday.com/articles/311990.php
Related Posts
-
Pets may be linked to slower cognitive decline
Posted on Mar 24, 2022
-
Poor score on simple memory test may be linked to Alzheimer’s biomarkers
Posted on Mar 15, 2022
-
Hypertension in young adults affects brain later
Posted on Mar 8, 2022
-
Being lonely more often may raise dementia risk
Posted on Mar 3, 2022
Tags
Share This
